Viewing StudyNCT06487078



Ignite Creation Date: 2024-07-17 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06487078
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-05
First Post: 2024-06-05

Brief Title: Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-15
Start Date Type: ESTIMATED
Primary Completion Date: 2028-11-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-11-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-05
First Submit QC Date: None
Study First Post Date: 2024-07-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-01
Last Update Post Date: 2024-07-05
Last Update Post Date Type: ACTUAL